These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24284393)

  • 61. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expanding spectrum of prion diseases.
    Ayers JI; Paras NA; Prusiner SB
    Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
    Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
    Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
    Melki R
    J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prion-like features of misfolded Aβ and tau aggregates.
    Morales R; Callegari K; Soto C
    Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model.
    Yuste-Checa P; Trinkaus VA; Riera-Tur I; Imamoglu R; Schaller TF; Wang H; Dudanova I; Hipp MS; Bracher A; Hartl FU
    Nat Commun; 2021 Aug; 12(1):4863. PubMed ID: 34381050
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tau, prions and Aβ: the triad of neurodegeneration.
    Reiniger L; Lukic A; Linehan J; Rudge P; Collinge J; Mead S; Brandner S
    Acta Neuropathol; 2011 Jan; 121(1):5-20. PubMed ID: 20473510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Hybrid Model to Study Amyloid Cross-Toxicity.
    Henriquez G; Mendez L; Narayan M
    ACS Chem Neurosci; 2020 Feb; 11(3):228-230. PubMed ID: 31920071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
    Jucker M; Walker LC
    Ann Neurol; 2011 Oct; 70(4):532-40. PubMed ID: 22028219
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurodegenerative diseases: expanding the prion concept.
    Walker LC; Jucker M
    Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insights into the thermodynamics of copper association with amyloid-β, α-synuclein and prion proteins.
    Hong L; Simon JD
    Metallomics; 2011 Mar; 3(3):262-6. PubMed ID: 21116546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Q&A with Zhentao Zhang.
    Zhang Z
    Cell Rep; 2024 Mar; 43(3):113969. PubMed ID: 38483901
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Propagating sticky matters: an update on "prion-like" templated misfolding in neurodegenerative disorders.
    Frank S; Tolnay M
    Brain Pathol; 2013 May; 23(3):319-20. PubMed ID: 23587137
    [No Abstract]   [Full Text] [Related]  

  • 76. Tunneling nanotubes: A possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases.
    Abounit S; Wu JW; Duff K; Victoria GS; Zurzolo C
    Prion; 2016 Sep; 10(5):344-351. PubMed ID: 27715442
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation.
    Tarutani A; Suzuki G; Shimozawa A; Nonaka T; Akiyama H; Hisanaga S; Hasegawa M
    J Biol Chem; 2016 Sep; 291(36):18675-88. PubMed ID: 27382062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro aggregation assays for the characterization of α-synuclein prion-like properties.
    Narkiewicz J; Giachin G; Legname G
    Prion; 2014; 8(1):19-32. PubMed ID: 24552879
    [TBL] [Abstract][Full Text] [Related]  

  • 79. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.
    Legname G; Scialò C
    Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The sulfation code for propagation of neurodegeneration.
    Yamada M; Hamaguchi T
    J Biol Chem; 2018 Jul; 293(27):10841-10842. PubMed ID: 29980653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.